HPV16 E6 induces chromosomal instability due to polar chromosomes caused by E6AP-dependent degradation of the mitotic kinesin CENP-E.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
04 04 2023
Historique:
medline: 31 3 2023
entrez: 29 3 2023
pubmed: 30 3 2023
Statut: ppublish

Résumé

Chromosome segregation during mitosis is highly regulated to ensure production of genetically identical progeny. Recurrent mitotic errors cause chromosomal instability (CIN), a hallmark of tumors. The E6 and E7 oncoproteins of high-risk human papillomavirus (HPV), which causes cervical, anal, and head and neck cancers (HNC), cause mitotic defects consistent with CIN in models of anogenital cancers, but this has not been studied in the context of HNC. Here, we show that HPV16 induces a specific type of CIN in patient HNC tumors, patient-derived xenografts, and cell lines, which is due to defects in chromosome congression. These defects are specifically induced by the HPV16 oncogene E6 rather than E7. We show that HPV16 E6 expression causes degradation of the mitotic kinesin CENP-E, whose depletion produces chromosomes that are chronically misaligned near spindle poles (polar chromosomes) and fail to congress. Though the canonical oncogenic role of E6 is the degradation of the tumor suppressor p53, CENP-E degradation and polar chromosomes occur independently of p53. Instead, E6 directs CENP-E degradation in a proteasome-dependent manner via the E6-associated ubiquitin protein ligase E6AP/UBE3A. This study reveals a mechanism by which HPV induces CIN, which may impact HPV-mediated tumor initiation, progression, and therapeutic response.

Identifiants

pubmed: 36989302
doi: 10.1073/pnas.2216700120
pmc: PMC10083562
doi:

Substances chimiques

Kinesins EC 3.6.4.4
Oncogene Proteins, Viral 0
Papillomavirus E7 Proteins 0
Tumor Suppressor Protein p53 0
Ubiquitin-Protein Ligases EC 2.3.2.27
UBE3A protein, human EC 2.3.2.26

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2216700120

Subventions

Organisme : NIDCR NIH HHS
ID : P50 DE026787
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA014520
Pays : United States
Organisme : NIH HHS
ID : S10 OD023526
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA234904
Pays : United States
Organisme : NCI NIH HHS
ID : K08 CA256166
Pays : United States
Organisme : NCI NIH HHS
ID : P50 CA278595
Pays : United States
Organisme : NCI NIH HHS
ID : R35 CA210807
Pays : United States
Organisme : NCI NIH HHS
ID : P01 CA022443
Pays : United States
Organisme : NCI NIH HHS
ID : T32 CA009135
Pays : United States

Références

Cell Rep. 2016 Jun 21;15(12):2679-91
pubmed: 27292643
Virology. 2009 Feb 20;384(2):260-5
pubmed: 19135222
Dev Cell. 2002 Sep;3(3):351-65
pubmed: 12361599
Dev Cell. 2016 Dec 19;39(6):638-652
pubmed: 27997823
Cell. 2015 Dec 17;163(7):1641-54
pubmed: 26687355
Cell Cycle. 2010 May;9(9):1711-6
pubmed: 20404532
Sci Transl Med. 2021 Sep 08;13(610):eabd4811
pubmed: 34516829
J Virol. 2020 Aug 31;94(18):
pubmed: 32641480
J Biol Chem. 2019 Oct 11;294(41):14860-14875
pubmed: 31492752
Proc Natl Acad Sci U S A. 2004 Mar 30;101(13):4459-64
pubmed: 15070740
Int J Cancer. 2015 Jan 1;136(1):98-107
pubmed: 24817381
Proc Natl Acad Sci U S A. 2009 Nov 10;106(45):19108-13
pubmed: 19855003
Int J Cancer. 2013 Feb 15;132(4):882-90
pubmed: 22821242
J Cell Sci. 2018 Aug 16;131(16):
pubmed: 30115751
Cell. 1993 Nov 5;75(3):495-505
pubmed: 8221889
Mol Cancer Res. 2021 Jan;19(1):112-123
pubmed: 32948674
J Clin Pathol. 2009 Oct;62(10):870-8
pubmed: 19706632
J Cell Biol. 2003 Aug 18;162(4):551-63
pubmed: 12925705
Cancer Res Commun. 2023 Jan 12;3(1):54-65
pubmed: 36968230
J Cancer Res Clin Oncol. 2017 Nov;143(11):2341-2350
pubmed: 28752235
Oncotarget. 2019 Apr 12;10(28):2660-2674
pubmed: 31105868
Biology (Basel). 2017 Feb 17;6(1):
pubmed: 28218637
Cell Cycle. 2019 Aug;18(15):1702-1713
pubmed: 31179849
Cancer Cell. 2018 Apr 9;33(4):676-689.e3
pubmed: 29622463
Cancer Cell. 2007 Jan;11(1):25-36
pubmed: 17189716
Proc Natl Acad Sci U S A. 2000 Aug 29;97(18):10002-7
pubmed: 10944189
Nature. 2009 Jul 9;460(7252):278-82
pubmed: 19506557
J Virol. 2003 Nov;77(22):12331-5
pubmed: 14581569
Clin Cancer Res. 2013 Feb 15;19(4):855-64
pubmed: 23251001
Ann Oncol. 2015 Oct;26(10):2180-92
pubmed: 26153498
Cell. 2010 Aug 6;142(3):444-55
pubmed: 20691903
PLoS One. 2009 Aug 10;4(8):e6564
pubmed: 19668340
Semin Cell Dev Biol. 2013 Apr;24(4):370-9
pubmed: 23416057
Virology. 2008 Mar 1;372(1):157-64
pubmed: 18036631
Proc Natl Acad Sci U S A. 2004 Jun 8;101(23):8699-704
pubmed: 15159543
Mol Biol Cell. 2016 Jul 1;27(13):1981-9
pubmed: 27146113
Cancer J. 2015 May-Jun;21(3):138-46
pubmed: 26049691
Biochem Biophys Res Commun. 2006 Jun 23;345(1):394-402
pubmed: 16682006
Am J Pathol. 1992 Feb;140(2):497-502
pubmed: 1310833
Cancer Res. 2005 Sep 15;65(18):8266-73
pubmed: 16166303
Proc Natl Acad Sci U S A. 2012 Dec 26;109(52):E3659-67
pubmed: 23236152
Cancer Res. 2002 Dec 1;62(23):7075-82
pubmed: 12460929
Cell. 2006 Dec 1;127(5):983-97
pubmed: 17129783
EMBO J. 1991 Dec;10(13):4129-35
pubmed: 1661671
Cell Rep. 2018 Apr 3;23(1):194-212.e6
pubmed: 29617660
J Clin Oncol. 2011 Nov 10;29(32):4294-301
pubmed: 21969503
J Cell Sci. 2001 Dec;114(Pt 24):4385-95
pubmed: 11792804
Trends Genet. 2008 Sep;24(9):457-66
pubmed: 18675487
Cell. 1991 Jun 14;65(6):1053-61
pubmed: 1828392
Cancer Cell. 2009 Dec 8;16(6):475-86
pubmed: 19962666
Nature. 2017 Aug 24;548(7668):461-465
pubmed: 28738408
Radiother Oncol. 2013 May;107(2):242-6
pubmed: 23602369
Proc Natl Acad Sci U S A. 2010 Mar 30;107(13):5839-44
pubmed: 20167803
Oncogene. 2002 Oct 24;21(49):7507-13
pubmed: 12386813
Mol Biol Cell. 2017 Jul 15;28(15):2035-2041
pubmed: 28539402
J Virol. 2007 Dec;81(24):13533-43
pubmed: 17913829
Semin Radiat Oncol. 2021 Oct;31(4):265-273
pubmed: 34455982
J Cell Biol. 2005 Apr 11;169(1):49-60
pubmed: 15824131
J Virol. 2003 Jun;77(12):6957-64
pubmed: 12768014
J Cell Sci. 1996 May;109 ( Pt 5):961-9
pubmed: 8743943
J Cell Sci. 2020 Aug 25;133(16):
pubmed: 32665320
N Engl J Med. 2010 Jul 1;363(1):24-35
pubmed: 20530316
J Low Genit Tract Dis. 2016 Apr;20(2):165-8
pubmed: 26735147
Nat Rev Cancer. 2018 Apr;18(4):240-254
pubmed: 29497146
J Cell Sci. 2004 Mar 15;117(Pt 8):1577-89
pubmed: 15020684
J Cell Biol. 1994 Jun;125(6):1303-12
pubmed: 8207059
FASEB J. 2008 Feb;22(2):622-32
pubmed: 17898088
J Virol. 2001 Aug;75(16):7712-6
pubmed: 11462043
Cancer Cell. 2011 Jun 14;19(6):701-14
pubmed: 21665145
Cancer Discov. 2016 May;6(5):532-45
pubmed: 27001151
Mol Cell Biol. 1993 Aug;13(8):4918-27
pubmed: 8393140
Radiother Oncol. 2014 Dec;113(3):337-44
pubmed: 25216575
Cell Stem Cell. 2016 Feb 4;18(2):253-61
pubmed: 26669899
Dev Cell. 2017 Jun 19;41(6):638-651.e5
pubmed: 28633018
Viruses. 2015 Jul 02;7(7):3530-51
pubmed: 26147797
J Virol. 2014 Jun;88(11):6112-27
pubmed: 24648447
Cancer Res. 2007 Jan 1;67(1):160-6
pubmed: 17210695
J Natl Cancer Inst. 2008 Feb 20;100(4):261-9
pubmed: 18270337
Oncogene. 1992 Sep;7(9):1681-6
pubmed: 1323816
Cancer Res. 2003 Jan 15;63(2):476-83
pubmed: 12543805
Recent Results Cancer Res. 2015;200:39-60
pubmed: 26376871
PLoS One. 2014 Jun 26;9(6):e100995
pubmed: 24967635
Br J Cancer. 2018 Jun;118(12):1586-1595
pubmed: 29736010
Proc Natl Acad Sci U S A. 2012 Aug 14;109(33):E2205-14
pubmed: 22778409
Oncogene. 2007 Sep 20;26(43):6280-8
pubmed: 17438528
Cell. 2006 Dec 1;127(5):969-82
pubmed: 17129782
Nature. 2001 Jan 18;409(6818):355-9
pubmed: 11201745
Proc Natl Acad Sci U S A. 1992 May 15;89(10):4549-53
pubmed: 1316611
Oncogene. 2004 Apr 29;23(20):3561-71
pubmed: 15077181
Cancer Res. 2013 Aug 1;73(15):4791-800
pubmed: 23749640
Sci Transl Med. 2014 Mar 26;6(229):229ra43
pubmed: 24670687
Mol Cancer. 2011 May 24;10:61
pubmed: 21609466
Nat Rev Cancer. 2010 Aug;10(8):550-60
pubmed: 20592731
Oral Oncol. 2017 Jan;64:65-72
pubmed: 28024726
J Cell Biol. 2008 May 5;181(3):411-9
pubmed: 18443223
J Pathol. 1999 Sep;189(1):12-9
pubmed: 10451482
Life Sci Alliance. 2020 Jan 24;3(2):
pubmed: 31980556
Mod Pathol. 2001 Apr;14(4):279-84
pubmed: 11301343
Nat Commun. 2015 Jan 21;6:5990
pubmed: 25606712
Int J Cancer. 2003 Aug 20;106(2):167-71
pubmed: 12800190
Cancer Discov. 2014 Nov;4(11):1281-9
pubmed: 25107667
Nature. 2015 Jun 11;522(7555):179-84
pubmed: 26017310
Nat Commun. 2016 Feb 15;7:10754
pubmed: 26876972
Mol Biol Cell. 2015 May 15;26(10):1845-56
pubmed: 25808490
EMBO J. 2014 Feb 18;33(4):385-99
pubmed: 24510915
Int J Gynecol Pathol. 1997 Jan;16(1):10-4
pubmed: 8986526
Oncotarget. 2017 Mar 21;8(12):19491-19506
pubmed: 28061478
Proc Natl Acad Sci U S A. 2013 Oct 29;110(44):E4134-41
pubmed: 24133140
Semin Radiat Oncol. 2022 Jan;32(1):54-63
pubmed: 34861996
Mol Biol Cell. 2005 Mar;16(3):1095-107
pubmed: 15616186

Auteurs

Pippa F Cosper (PF)

Department of Human Oncology, University of Wisconsin-Madison, Madison, WI 53705.
University of Wisconsin Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI 53705.

Laura C F Hrycyniak (LCF)

Molecular and Cellular Pharmacology Graduate Training Program, University of Wisconsin-Madison, Madison, WI 53705.

Maha Paracha (M)

Department of Human Oncology, University of Wisconsin-Madison, Madison, WI 53705.

Denis L Lee (DL)

Department of Oncology, McArdle Laboratory for Cancer Research, University of Wisconsin-Madison, Madison, WI 53705.

Jun Wan (J)

Physiology Graduate Training Program, University of Wisconsin-Madison, Madison, WI 53705.

Kathryn Jones (K)

Department of Human Oncology, University of Wisconsin-Madison, Madison, WI 53705.

Sophie A Bice (SA)

University of Wisconsin School of Medicine and Public Health, Madison, WI 53705.

Kwangok Nickel (K)

Department of Human Oncology, University of Wisconsin-Madison, Madison, WI 53705.

Samyukta Mallick (S)

Department of Pathology and Cell Biology at the Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY 10032.
Integrated Program in Cellular, Molecular, and Biomedical Studies, Columbia University, New York, NY 10032.

Alison M Taylor (AM)

Department of Pathology and Cell Biology at the Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY 10032.

Randall J Kimple (RJ)

Department of Human Oncology, University of Wisconsin-Madison, Madison, WI 53705.
University of Wisconsin Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI 53705.

Paul F Lambert (PF)

University of Wisconsin Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI 53705.
Department of Oncology, McArdle Laboratory for Cancer Research, University of Wisconsin-Madison, Madison, WI 53705.

Beth A Weaver (BA)

University of Wisconsin Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI 53705.
Department of Oncology, McArdle Laboratory for Cancer Research, University of Wisconsin-Madison, Madison, WI 53705.
Department of Cell and Regenerative Biology, University of Wisconsin-Madison, Madison, WI 53705.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH